Polymorphisms in immunoregulatory genes: towards individualized immunosuppressive therapy?

American journal of pharmacogenomics : genomics-related research in drug development and clinical practice

Volumn 2, Issue 1, 2002, Pages 13-23

  Daly, Ann K ^a   Day, Christopher P ^a   Donaldson, Peter T ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

GENETIC POLYMORPHISM; GENETICS; HUMAN; PHARMACOGENETICS; REVIEW;

CYTOKINES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHARMACOGENETICS; POLYMORPHISM, GENETIC;

EID: 0036046824     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200202010-00002     Document Type: Review

References (112)

1. 1. J Gugenheim D Samuel M Reynes 1990 Liver-transplantation across ABO blood-group barriers Lancet 336 519 23 1975036 1:STN:280:DyaK3czlsFOitQ%3D%3D 10.1016/0140-6736(90)92082-S Gugenheim J, Samuel D, Reynes M, et al. Liver-transplantation across ABO blood-group barriers. Lancet 1990; 336: 519–23
2. 2. P Donaldson J Underhill D Doherty 1993 Influence of human-leukocyte antigen matching on liver allograft survival and rejection — the dualistic effect Hepatology 17 1008 15 8514248 1:STN:280:DyaK3s3ptlWgtw%3D%3D 10.1002/hep.1840170611 Donaldson P, Underhill J, Doherty D, et al. Influence of human-leukocyte antigen matching on liver allograft survival and rejection — the dualistic effect. Hepatology 1993; 17: 1008–15
3. 3. PT Donaldson R Williams 1997 Cross-matching in liver transplantation Transplantation 63 789 94 9089216 1:STN:280:DyaK2s3ksVektA%3D%3D 10.1097/00007890-199703270-00001 Donaldson PT, Williams R. Cross-matching in liver transplantation. Transplantation 1997; 63: 789–94
4. 4. PJ Morris 1994 HLA matching and cardiac transplantation N Engl J Med 330 857 8 8114840 1:STN:280:DyaK2c7lvV2qsw%3D%3D 10.1056/NEJM199403243301210 Morris PJ. HLA matching and cardiac transplantation. N Engl J Med 1994; 330: 857–8
5. 5. T McDowell J Symons R Ploski 1995 A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism Arthritis Rheum 38 221 8 7848312 1:STN:280:DyaK2M7ltFSmsg%3D%3D 10.1002/art.1780380210 McDowell T, Symons J, Ploski R, et al. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 1995; 38: 221–8
6. 6. K Kornman F Giovine di 1998 Genetic variation in cytokine expression: a risk factor for the severity of adult periodontitis Ann Periodontol 3 327 8 9722717 1:STN:280:DyaK1czovF2nsw%3D%3D 10.1902/annals.1998.3.1.327 Kornman K, di Giovine F. Genetic variation in cytokine expression: a risk factor for the severity of adult periodontitis. Ann Periodontol 1998; 3: 327–8
7. 7. G Zuliani HH Hobbs 1990 A high-frequency of length polymorphisms in repeated sequences adjacent to Alu sequences Am J Hum Genet 46 963 9 2339694 1:CAS:528:DyaK3cXltFShtr4%3D Zuliani G, Hobbs HH. A high-frequency of length polymorphisms in repeated sequences adjacent to Alu sequences. Am J Hum Genet 1990; 46: 963–9
8. 8. S Todd SL Naylor 1991 Dinucleotide repeat polymorphism in the human interleukin-1, alpha gene (Il1a) Nucleic Acids Res 19 3756 Todd S, Naylor SL. Dinucleotide repeat polymorphism in the human interleukin-1, alpha gene (Il1a). Nucleic Acids Res 1991; 19: 3756
9. 9. F Pociot J Molvig L Wogensen 1992 A TaqI polymorphism in the human interleukin-1-beta (IL-1-beta) gene correlates with IL-1-beta secretion in vitro Eur J Clin Invest 22 396 402 1353022 1:CAS:528:DyaK3sXitVKltA%3D%3D 10.1111/j.1365-2362.1992.tb01480.x Pociot F, Molvig J, Wogensen L, et al. A TaqI polymorphism in the human interleukin-1-beta (IL-1-beta) gene correlates with IL-1-beta secretion in vitro. Eur J Clin Invest 1992; 22: 396–402
10. 10. JF Guasch RM Bertina PH Reitsma 1996 Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity Cytokine 8 598 602 8894434 1:CAS:528:DyaK28XmtFWrsLs%3D 10.1006/cyto.1996.0080 Guasch JF, Bertina RM, Reitsma PH. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. Cytokine 1996; 8: 598–602
11. 11. BL Langdahl E Lokke M Carstens 2000 Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1 beta gene J Bone Miner Res 15 402 14 10750554 1:CAS:528:DC%2BD3cXitFaksbc%3D 10.1359/jbmr.2000.15.3.402 Langdahl BL, Lokke E, Carstens M, et al. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1 beta gene. J Bone Miner Res 2000; 15: 402–14
12. 12. J Tarlow A Blakemore A Lennard 1993 Polymorphism in human IL-1 receptor antagonist intron 2 gene is caused by variable numbers of a 86 bp tandem repeat Hum Genet 91 403 4 8500797 1:CAS:528:DyaK3sXlsFyjtro%3D 10.1007/BF00217368 Tarlow J, Blakemore A, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist intron 2 gene is caused by variable numbers of a 86 bp tandem repeat. Hum Genet 1993; 91: 403–4
13. 13. LJ Rosenwasser L Borish 1997 Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10) Am J Respir Crit Care Med 156 S152 5 9351597 1:STN:280:DyaK1c%2FhtF2lsA%3D%3D Rosenwasser LJ, Borish L. Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 1997; 156: S152–5
14. 14. I Suzuki E Yamaguchi N Hizawa 1999 A new polymorphism in the 5’ flanking region of the human interleukin IL-4 gene Immunogenetics 49 738 9 10369939 1:CAS:528:DyaK1MXjtlKnsLs%3D 10.1007/s002510050677 Suzuki I, Yamaguchi E, Hizawa N, et al. A new polymorphism in the 5’ flanking region of the human interleukin IL-4 gene. Immunogenetics 1999; 49: 738–9
15. 15. C Ober A Tsalenko R Parry 2000 A second generation genomewide screen for asthma-susceptibility alleles in a founder population Am J Hum Genet 67 1154 62 11022011 1:CAS:528:DC%2BD3cXot1antbc%3D Ober C, Tsalenko A, Parry R, et al. A second generation genomewide screen for asthma-susceptibility alleles in a founder population. Am J Hum Genet 2000; 67: 1154–62
16. 16. D Fishman G Faulds R Jeffery 1998 The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1369 76 9769329 1:CAS:528:DyaK1cXmsFOrsrY%3D 10.1172/JCI2629 Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998; 102: 1369–76
17. 17. CF Terry V Loukaci FR Green 2000 Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation J Biol Chem 275 18138 44 10747905 1:CAS:528:DC%2BD3cXktlymtLw%3D 10.1074/jbc.M000379200 Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138–44
18. 18. AW Gibson JC Edberg JM Wu 2001 Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus J Immunol 166 3915 22 11238636 1:CAS:528:DC%2BD3MXitVGmsrw%3D Gibson AW, Edberg JC, Wu JM, et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001; 166: 3915–22
19. 19. DM Turner DM Williams D Sankaran 1997 An investigation of polymorphism in the interleukin-10 gene promoter Eur J Immunogenet 24 1 8 9043871 1:CAS:528:DyaK2sXhsFCjsL0%3D 10.1111/j.1365-2370.1997.tb00001.x Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1–8
20. 20. J Eskdale V Keijsers T Huizinga 1999 Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus Genes Immun 1 151 5 11196662 1:CAS:528:DC%2BD3cXktlyhu70%3D 10.1038/sj.gene.6363656 Eskdale J, Keijsers V, Huizinga T, et al. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1999; 1: 151–5
21. 21. K Deichmann J Bardutzky J Forster 1997 Common polymorphisms in the coding part of the IL4-receptor gene Biochem Biophys Res Commun 231 696 7 9070874 1:CAS:528:DyaK2sXhsFWku7g%3D 10.1006/bbrc.1997.6115 Deichmann K, Bardutzky J, Forster J, et al. Common polymorphisms in the coding part of the IL4-receptor gene. Biochem Biophys Res Commun 1997; 231: 696–7
22. 22. GKK Hershey MF Friedrich LA Esswein 1997 The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor N Engl J Med 337 1720 5 9392697 1:STN:280:DyaK1c%2FktFyjsQ%3D%3D 10.1056/NEJM199712113372403 Hershey GKK, Friedrich MF, Esswein LA, et al. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997; 337: 1720–5
23. 23. T Skoog FM Hooft van’t B Kallin 1999 A common functional polymorphism (C-> A substitution at position-863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha Hum Mol Genet 8 1443 9 10400991 1:CAS:528:DyaK1MXltFagtLo%3D 10.1093/hmg/8.8.1443 Skoog T, van’t Hooft FM, Kallin B, et al. A common functional polymorphism (C-> A substitution at position-863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet 1999; 8: 1443–9
24. 24. AM Uglialoro D Turbay PA Pesavento 1998 Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter Tissue Antigens 52 359 67 9820599 1:CAS:528:DyaK1cXntVGqsL8%3D 10.1111/j.1399-0039.1998.tb03056.x Uglialoro AM, Turbay D, Pesavento PA, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor-alpha gene promoter. Tissue Antigens 1998; 52: 359–67
25. 25. SM Herrmann S Ricard V Nicaud 1998 Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity Eur J Clin Invest 28 59 66 9502188 1:CAS:528:DyaK1cXhtlOrtbg%3D 10.1046/j.1365-2362.1998.00244.x Herrmann SM, Ricard S, Nicaud V, et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 1998; 28: 59–66
26. 26. BMN Brinkman TWJ Huizinga SS Kurban 1997 Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 36 516 21 9189051 1:CAS:528:DyaK2sXkt1ertrk%3D 10.1093/rheumatology/36.5.516 Brinkman BMN, Huizinga TWJ, Kurban SS, et al. Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease? Br J Rheumatol 1997; 36: 516–21
27. 27. AG Wilson N Devries F Pociot 1993 An allelic polymorphism within the human tumor-necrosis-factor-alpha promoter region is strongly associated with HLA-Al, HLA-B8, and HLA-DR3 alleles J Exp Med 177 557 60 8426126 1:CAS:528:DyaK3sXnvFWgtw%3D%3D 10.1084/jem.177.2.557 Wilson AG, Devries N, Pociot F, et al. An allelic polymorphism within the human tumor-necrosis-factor-alpha promoter region is strongly associated with HLA-Al, HLA-B8, and HLA-DR3 alleles. J Exp Med 1993; 177: 557–60
28. 28. S Dalfonso PM Richiardi 1994 A Polymorphic variation in a putative regulation box of the TNFA promoter region Immunogenetics 39 150 4 1:STN:280:DyaK2c7gt1yjuw%3D%3D Dalfonso S, Richiardi PM. A Polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994; 39: 150–4
29. 29. S Dalfonso PM Richiardi 1996 An intragenic polymorphism in the human tumor necrosis factor alpha (TNFA) chain-encoding gene Immunogenetics 44 321 2 1:CAS:528:DyaK28XlvVWksbw%3D 10.1007/BF02602566 Dalfonso S, Richiardi PM. An intragenic polymorphism in the human tumor necrosis factor alpha (TNFA) chain-encoding gene. Immunogenetics 1996; 44: 321–2
30. 30. IA Udalova SA Nedospasov GC Webb 1993 Highly informative typing of the human TNF locus using 6 adjacent polymorphic markers Genomics 16 180 6 8486354 1:CAS:528:DyaK3sXkvVyjtLs%3D 10.1006/geno.1993.1156 Udalova IA, Nedospasov SA, Webb GC, et al. Highly informative typing of the human TNF locus using 6 adjacent polymorphic markers. Genomics 1993; 16: 180–6
31. 31. L Fugger N Morling LP Ryder 1989 NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF-Alpha) region in primary biliary-cirrhosis and in healthy Danes Scand J Immunol 30 185 9 2569760 1:STN:280:DyaL1Mzks1Klug%3D%3D 10.1111/j.1365-3083.1989.tb01200.x Fugger L, Morling N, Ryder LP, et al. NcoI restriction fragment length polymorphism (RFLP) of the tumor necrosis factor (TNF-Alpha) region in primary biliary-cirrhosis and in healthy Danes. Scand J Immunol 1989; 30: 185–9
32. 32. S Ferencik M Lindemann B Horsthemke 1992 A new restriction-fragment-length-polymorphism of the human TNF-B gene detected by AspHI digest Eur J Immunogenet 19 425 30 1362079 1:CAS:528:DyaK3sXhsVGltLY%3D 10.1111/j.1744-313X.1992.tb00086.x Ferencik S, Lindemann M, Horsthemke B, et al. A new restriction-fragment-length-polymorphism of the human TNF-B gene detected by AspHI digest. Eur J Immunogenet 1992; 19: 425–30
33. 33. G Messer U Spengler MC Jung 1991 Polymorphic structure of the tumor-necrosis-factor (TNF) locus — an NcoI polymorphism in the 1st intron of the human TNF-beta gene correlates with a variant amino-acid in position-26 and a reduced level of TNF-beta production J Exp Med 173 209 19 1670638 1:CAS:528:DyaK3MXls1Oksg%3D%3D 10.1084/jem.173.1.209 Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor-necrosis-factor (TNF) locus — an NcoI polymorphism in the 1st intron of the human TNF-beta gene correlates with a variant amino-acid in position-26 and a reduced level of TNF-beta production. J Exp Med 1991; 173: 209–19
34. 34. F Cambien S Ricard A Troesch 1996 Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l’Infarctus du Myocarde (ECTIM) Study Hypertension 28 881 7 8901839 1:CAS:528:DyaK28XmvVKltb4%3D 10.1161/01.HYP.28.5.881 Cambien F, Ricard S, Troesch A, et al. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l’Infarctus du Myocarde (ECTIM) Study. Hypertension 1996; 28: 881–7
35. 35. A Ruiz-Linares 1993 Dinucleotide repeat polymorphism in the interferon-gamma (IFNG) gene Hum Mol Genet 2 1508 8242087 1:CAS:528:DyaK2cXhvFCh 10.1093/hmg/2.9.1508 Ruiz-Linares A. Dinucleotide repeat polymorphism in the interferon-gamma (IFNG) gene. Hum Mol Genet 1993; 2: 1508
36. 36. V Pravica C Perrey A Stevens 2000 A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production Hum Immunol 61 863 6 11053629 1:CAS:528:DC%2BD3cXosVWlu7s%3D 10.1016/S0198-8859(00)00167-1 Pravica V, Perrey C, Stevens A, et al. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000; 61: 863–6
37. 37. V Guedraitis B He J Hillert 1999 Mutation screening of the interferon-gamma gene as a candidate gene for multiple sclerosis Eur J Immunogenet 26 257 9 10.1046/j.1365-2370.1999.00140.x Guedraitis V, He B, Hillert J. Mutation screening of the interferon-gamma gene as a candidate gene for multiple sclerosis. Eur J Immunogenet 1999; 26: 257–9
38. 38. K Deichmann A Heinzmann E Bruggenolte 1996 An Mse I RFLP in the human CTLA4 promotor Biochem Biophys Res Commun 225 817 8 8780695 1:CAS:528:DyaK28Xlt1Wqu7g%3D 10.1006/bbrc.1996.1256 Deichmann K, Heinzmann A, Bruggenolte E, et al. An Mse I RFLP in the human CTLA4 promotor. Biochem Biophys Res Commun 1996; 225: 817–8
39. 39. K Harper C Balzano E Rouvier 1991 CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location J Immunol 147 1037 44 1713603 1:CAS:528:DyaK3MXmslajt7c%3D Harper K, Balzano C, Rouvier E, et al. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991; 147: 1037–44
40. 40. MH Polymeropoulos H Xiao DS Rath 1991 Dinucleotide repeat polymorphism at the human CTLA4 gene Nucleic Acids Res 19 4018 Polymeropoulos MH, Xiao H, Rath DS, et al. Dinucleotide repeat polymorphism at the human CTLA4 gene. Nucleic Acids Res 1991; 19: 4018
41. 41. M Samson F Libert BJ Doranz 1996 Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 382 722 5 8751444 1:CAS:528:DyaK28Xlt1ylt7s%3D 10.1038/382722a0 Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722–5
42. 42. MA AnsariLari XM Liu ML Metzker 1997 The extent of genetic variation in the CCR5 gene Nat Genet 16 221 2 1:CAS:528:DyaK2sXktFCrsb4%3D 10.1038/ng0797-221 AnsariLari MA, Liu XM, Metzker ML, et al. The extent of genetic variation in the CCR5 gene. Nat Genet 1997; 16: 221–2
43. 43. C Quillent E Oberlin J Braun 1998 HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene Lancet 351 14 8 9433423 1:CAS:528:DyaK1cXmt12rsQ%3D%3D 10.1016/S0140-6736(97)09185-X Quillent C, Oberlin E, Braun J, et al. HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998; 351:14–8
44. 44. DH McDermott PA Zimmerman F Guignard 1998 CCR5 promoter polymorphism and HIV-1 disease progression Lancet 352 866 70 9742978 1:CAS:528:DyaK1cXmtlOlsbk%3D 10.1016/S0140-6736(98)04158-0 McDermott DH, Zimmerman PA, Guignard F, et al. CCR5 promoter polymorphism and HIV-1 disease progression. Lancet 1998; 352: 866–70
45. 45. LG Kostrikis AU Neumann B Thomson 1999 Apolymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants J Virol 73 10264 71 10559343 1:CAS:528:DyaK1MXnsV2mu78%3D Kostrikis LG, Neumann AU, Thomson B, et al. Apolymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol 1999; 73: 10264–71
46. 46. JJ Maher 1999 Cytokines: overview Semin Liver Dis 19 109 15 10422194 1:CAS:528:DyaK1MXkvFeisro%3D 10.1055/s-2007-1007103 Maher JJ. Cytokines: overview. Semin Liver Dis 1999; 19: 109–15
47. 47. DK Imagawa JM Millis KM Olthoff 1990 The role of tumor-necrosis-factor in allograft-rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver-transplantation Transplantation 50 219 25 2382288 1:CAS:528:DyaK3cXmtV2ltrY%3D 10.1097/00007890-199008000-00009 Imagawa DK, Millis JM, Olthoff KM, et al. The role of tumor-necrosis-factor in allograft-rejection. I. Evidence that elevated levels of tumor necrosis factor-alpha predict rejection following orthotopic liver-transplantation. Transplantation 1990; 50: 219–25
48. 48. RD Allen 1999 Polymorphism of the human TNF-alpha promoter — random variation or functional diversity? Mol Immunol 36 1017 27 10698305 1:CAS:528:DC%2BD3cXht1Gkt7o%3D 10.1016/S0161-5890(99)00127-3 Allen RD. Polymorphism of the human TNF-alpha promoter — random variation or functional diversity? Mol Immunol 1999; 36: 1017–27
49. 49. H Hohjoh K Tokunaga 2001 Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter Genes Immun 2 105 9 11393654 1:CAS:528:DC%2BD3MXjtFKnur0%3D 10.1038/sj.gene.6363721 Hohjoh H, Tokunaga K. Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun 2001; 2: 105–9
50. 50. D Turner SCD Grant N Yonan 1997 Cytokine gene polymorphism and heart transplant rejection Transplantation 64 776 9 9311720 1:STN:280:DyaK2svls1CjtA%3D%3D 10.1097/00007890-199709150-00021 Turner D, Grant SCD, Yonan N, et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997; 64: 776–9
51. 51. AN Abdallah P Cucchi-Mouillot N Biteau 1999 Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection Eur J Immunogenet 26 249 55 10457886 1:CAS:528:DyaK1MXlslyit74%3D 10.1046/j.1365-2370.1999.00128.x Abdallah AN, Cucchi-Mouillot P, Biteau N, et al. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-alpha levels in heart-transplant patients suffering or not suffering from severe rejection. Eur J Immunogenet 1999; 26: 249–55
52. 52. SE Marshall AJ McLaren NA Haldar 2000 The impact of recipient cytokine genotype on acute rejection after renal transplantation Transplantation 70 1485 91 11118095 1:STN:280:DC%2BD3M%2Fns1yrtQ%3D%3D 10.1097/00007890-200011270-00016 Marshall SE, McLaren AJ, Haldar NA, et al. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation 2000; 70: 1485–91
53. 53. F Poli L Boschiero F Giannoni 2000 Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation Cytokine 12 1778 83 11097747 1:CAS:528:DC%2BD3cXotlKlsLk%3D 10.1006/cyto.2000.0779 Poli F, Boschiero L, Giannoni F, et al. Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation. Cytokine 2000; 12:1778–83
54. 54. S Sahoo S Kang S Supran 2000 Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation Transplantation 69 880 4 10755544 1:CAS:528:DC%2BD3cXis1CgtL4%3D 10.1097/00007890-200003150-00036 Sahoo S, Kang S, Supran S, et al. Tumor necrosis factor genetic polymorphisms correlate with infections after renal transplantation. Transplantation 2000; 69: 880–4
55. 55. D Sankaran A Asderakis S Ashraf 1999 Cytokine gene polymorphisms predict acute graft rejection following renal transplantation Kidney Int 56 281 8 10411704 1:CAS:528:DyaK1MXksVyjsro%3D 10.1046/j.1523-1755.1999.00536.x Sankaran D, Asderakis A, Ashraf S, et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999; 56: 281–8
56. 56. K Agarwal AK Daly JB Leathart 2000 Polymorphisms of immunoregulatory genes: a step towards individually tailored immunosuppression [abstract]? Hepatology 32 748 10.1016/S0168-8278(00)80243-3 Agarwal K, Daly AK, Leathart JB, et al. Polymorphisms of immunoregulatory genes: a step towards individually tailored immunosuppression [abstract]? Hepatology 2000; 32: 748
57. 57. JR Jonsson C Hong DM Purdie 2001 Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation Liver Transpl 7 255 63 11244168 1:STN:280:DC%2BD3M3lvFOiug%3D%3D 10.1053/jlts.2001.22450 Jonsson JR, Hong C, Purdie DM, et al. Role of cytokine gene polymorphisms in acute rejection and renal impairment after liver transplantation. Liver Transpl 2001; 7: 255–63
58. 58. AJ Bathgate V Pravica C Perrey 2000 The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta 1 genes in acute hepatic allograft rejection Transplantation 69 1514 7 10798783 1:CAS:528:DC%2BD3cXjt1Kgur4%3D 10.1097/00007890-200004150-00054 Bathgate AJ, Pravica V, Perrey C, et al. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta 1 genes in acute hepatic allograft rejection. Transplantation 2000; 69: 1514–7
59. 59. P Donaldson M Manns 1999 Immunogenetics of liver diseases J Bircher J-P Benhamou N Mclntyre Oxford textbook of hepatology Oxford University Press Oxford 173 88 Donaldson P, Manns M. Immunogenetics of liver diseases. In: Bircher J, Benhamou J-P, Mclntyre N, et al., editors. Oxford textbook of hepatology. Oxford: Oxford University Press, 1999: 173–88
60. 60. S Cookson S Marshall P Gibbs 2000 The influence of recipient cytokine genotype on outcome following liver transplantation Immunology 101 66 [abstract] Cookson S, Marshall S, Gibbs P, et al. The influence of recipient cytokine genotype on outcome following liver transplantation [abstract]. Immunology 2000; 101: 66
61. 61. J Cavet PG Middleton M Segall 1999 Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants Blood 94 3941 6 10572111 1:CAS:528:DyaK1MXnslykurk%3D Cavet J, Middleton PG, Segall M, et al. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 1999; 94: 3941–6
62. 62. F Stuber M Petersen F Bokelmann 1996 A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis Crit Care Med 24 381 4 8625623 1:STN:280:DyaK287psVehtA%3D%3D 10.1097/00003246-199603000-00004 Stuber F, Petersen M, Bokelmann F, et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis. Crit Care Med 1996; 24: 381–4
63. 63. RB Freeman CL Tran J Mattoli 1999 Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation Transplantation 67 1005 10 10221485 10.1097/00007890-199904150-00012 Freeman RB, Tran CL, Mattoli J, et al. Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation. Transplantation 1999; 67: 1005–10
64. 64. N Gandhi D Goldman D Kahan 2001 Donor cytokine gene polymorphisms are associated with increased graft loss and dysfunction after transplant Transplant Proc 33 827 8 11267084 1:CAS:528:DC%2BD3MXitV2gtb4%3D 10.1016/S0041-1345(00)02333-2 Gandhi N, Goldman D, Kahan D, et al. Donor cytokine gene polymorphisms are associated with increased graft loss and dysfunction after transplant. Transplant Proc 2001; 33: 827–8
65. 65. SE Marshall AJ McLaren EF McKinney 2001 Donor cytokine genotype influences the development of acute rejection after renal transplantation Transplantation 71 469 76 11233912 1:CAS:528:DC%2BD3MXhvFegsbg%3D 10.1097/00007890-200102150-00022 Marshall SE, McLaren AJ, McKinney EF, et al. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 2001; 71: 469–76
66. 66. FS Digiovine GW Duff 1990 Interleukin-1 — the 1st Interleukin Immunol Today 11 13 20 1:CAS:528:DyaK3cXhsFKhsbk%3D 10.1016/0167-5699(90)90005-T Digiovine FS, Duff GW. Interleukin-1 — the 1st Interleukin. Immunol Today 1990; 11: 13–20
67. 67. J Vamvakopoulos 2001 Interleukin 1 gene polymorphisms Ann Rheum Dis 60 718 9 11436858 1:STN:280:DC%2BD3MznvFKhtA%3D%3D 10.1136/ard.60.7.718a Vamvakopoulos J. Interleukin 1 gene polymorphisms. Ann Rheum Dis 2001; 60: 718–9
68. 68. M Hurme S Santtila 1998 IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1 beta genes Eur J Immunol 28 2598 602 9710237 1:CAS:528:DyaK1cXlt1Shtbo%3D 10.1002/(SICI)1521-4141(199808)28:08<2598::AID-IMMU2598>3.0.CO;2-K Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1 beta genes. Eur J Immunol 1998; 28: 2598–602
69. 69. EM El-Omar M Carrington WH Chow 2000 Interleukin-1 polymorphisms associated with increased risk of gastric cancer Nature 404 398 402 10746728 1:CAS:528:DC%2BD3cXitlyltb4%3D 10.1038/35006081 El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398–402
70. 70. W Bernal N Jackson R Williams 1998 Association of interleukin-1 beta genotype with a poor outcome in acetaminophen induced acute liver failure Hepatology 28 673 [abstract] Bernal W, Jackson N, Williams R, et al. Association of interleukin-1 beta genotype with a poor outcome in acetaminophen induced acute liver failure [abstract]. Hepatology 1998; 28: 673
71. 71. P Donaldson K Agarwal A Craggs 2001 HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility Gut 48 397 402 11171832 1:CAS:528:DC%2BD3MXitlCjurs%3D 10.1136/gut.48.3.397 Donaldson P, Agarwal K, Craggs A, et al. HLA and interleukin 1 gene polymorphisms in primary biliary cirrhosis: associations with disease progression and disease susceptibility. Gut 2001; 48: 397–402
72. 72. H Cullup AM Dickinson GH Jackson 2001 Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants Br J Haematol 113 807 13 11380474 1:CAS:528:DC%2BD3MXkvFeht74%3D 10.1046/j.1365-2141.2001.02811.x Cullup H, Dickinson AM, Jackson GH, et al. Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants. Br J Haematol 2001; 113: 807–13
73. 73. A Craggs S West A Curtis 2001 Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from Northeast England Scand J Gastroenterol 36 1173 8 11686217 1:CAS:528:DC%2BD3MXotFGnsbY%3D 10.1080/00365520152584806 Craggs A, West S, Curtis A, et al. Absence of a genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn disease in multiple populations from Northeast England. Scand J Gastroenterol 2001; 36: 1173–8
74. 74. C Miki P McMaster AD Mayer 2000 Factors predicting perioperative cytokine response in patients undergoing liver transplantation Crit Care Med 28 351 4 10708165 1:STN:280:DC%2BD3c7ntVCgug%3D%3D 10.1097/00003246-200002000-00010 Miki C, McMaster P, Mayer AD, et al. Factors predicting perioperative cytokine response in patients undergoing liver transplantation. Crit Care Med 2000; 28: 351–4
75. 75. NH Cartwright LJ Keen AG Demaine 2001 A study of cytokine gene polymorphisms and protein secretion in renal transplantation Transpl Immunol 8 237 44 11316066 1:CAS:528:DC%2BD3MXjsFeqsLg%3D 10.1016/S0966-3274(01)00026-0 Cartwright NH, Keen LJ, Demaine AG, et al. A study of cytokine gene polymorphisms and protein secretion in renal transplantation. Transpl Immunol 2001; 8: 237–44
76. 76. E Crawley R Kay J Sillibourne 1999 Polymorphic haplotypes of the interleukin10 5’ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis Arthritis Rheum 42 1101 8 10366102 1:CAS:528:DyaK1MXktVegt70%3D 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y Crawley E, Kay R, Sillibourne J, et al. Polymorphic haplotypes of the interleukin10 5’ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101–8
77. 77. J Eskdale G Gallagher CL Verweij 1998 Interleukin 10 secretion in relation to human IL-10 locus haplotypes Proc Natl Acad Sci USA 95 9465 70 9689103 1:CAS:528:DyaK1cXltlCls70%3D 10.1073/pnas.95.16.9465 Eskdale J, Gallagher G, Verweij CL, et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA 1998; 95: 9465–70
78. 78. FJ Bijlsma AH Bruggink M Hartman 2001 No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation Tissue Antigens 57 151 3 11260510 1:CAS:528:DC%2BD3MXivVOrt74%3D 10.1034/j.1399-0039.2001.057002151.x Bijlsma FJ, Bruggink AH, Hartman M, et al. No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation. Tissue Antigens 2001; 57: 151–3
79. 79. KL Poole PJ Gibbs PR Evans 2001 Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study Transpl Immunol 8 259 65 11316069 1:CAS:528:DC%2BD3MXjsFeqsLc%3D 10.1016/S0966-3274(01)00030-2 Poole KL, Gibbs PJ, Evans PR, et al. Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study. Transpl Immunol 2001; 8: 259–65
80. 80. AE Postlethwaite MA Holness H Katai 1992 Human fibroblasts synthesize elevated levels of extracellular-matrix proteins in response to interleukin-4 J Clin Invest 90 1479 85 1401080 1:CAS:528:DyaK3sXltl2n 10.1172/JCI116015 Postlethwaite AE, Holness MA, Katai H, et al. Human fibroblasts synthesize elevated levels of extracellular-matrix proteins in response to interleukin-4. J Clin Invest 1992; 90: 1479–85
81. 81. C Ober SA Leavitt A Tsalenko 2000 Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations Am J Hum Genet 66 517 26 10677312 1:CAS:528:DC%2BD3cXitFyit7Y%3D 10.1086/302781 Ober C, Leavitt SA, Tsalenko A, et al. Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet 2000; 66: 517–26
82. 82. WA Border NA Noble 1994 Transforming growth-factor-beta in tissue fibrosis N Engl J Med 331 1286 92 7935686 1:CAS:528:DyaK2MXitlGksrs%3D 10.1056/NEJM199411103311907 Border WA, Noble NA. Transforming growth-factor-beta in tissue fibrosis. N Engl J Med 1994; 331: 1286–92
83. 83. JH Kehrl LM Wakefield AB Roberts 1986 Production of transforming growth-factor-beta by human lymphocytes-T and its potential role in the regulation of T-cell growth J Exp Med 163 1037 50 2871125 1:CAS:528:DyaL28Xit1ehu7s%3D 10.1084/jem.163.5.1037 Kehrl JH, Wakefield LM, Roberts AB, et al. Production of transforming growth-factor-beta by human lymphocytes-T and its potential role in the regulation of T-cell growth. J Exp Med 1986; 163: 1037–50
84. 84. A Khanna BG Li KH Stenzel 1994 Regulation of new DNA-synthesis in mammalian-cells by cyclosporin — demonstration of a transforming growth-factor-beta dependent mechanism of inhibition of cell-growth Transplantation 57 577 82 8116045 1:CAS:528:DyaK2cXktVSnsLY%3D Khanna A, Li BG, Stenzel KH, et al. Regulation of new DNA-synthesis in mammalian-cells by cyclosporin — demonstration of a transforming growth-factor-beta dependent mechanism of inhibition of cell-growth. Transplantation 1994; 57:577–82
85. 85. MAS Mohamed AD Burt H Robertson 2001 TGF-beta expression in protocol transplant liver biopsies: a comparative study between cyclosporin-A (CyA) and tacrolimus (FK 506) immunosuppression Transplant Proc 33 1378 80 11267336 1:CAS:528:DC%2BD3MXitV2msr4%3D 10.1016/S0041-1345(00)02518-5 Mohamed MAS, Burt AD, Robertson H, et al. TGF-beta expression in protocol transplant liver biopsies: a comparative study between cyclosporin-A (CyA) and tacrolimus (FK 506) immunosuppression. Transplant Proc 2001; 33: 1378–80
86. 86. MR Awad A El-Gamel P Hasleton 1998 Genotypic variation in the transforming growth factor-beta 1 gene: association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation Transplantation 66 1014 20 9808485 1:CAS:528:DyaK1cXnsFelurw%3D 10.1097/00007890-199810270-00009 Awad MR, El-Gamel A, Hasleton P, et al. Genotypic variation in the transforming growth factor-beta 1 gene: association with transforming growth factor-pi production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66: 1014–20
87. 87. CG Densem IV Hutchinson A Cooper 2000 Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculo-pathy following cardiac transplantation J Heart Lung Transplant 19 551 6 10867335 1:STN:280:DC%2BD3czotlOksA%3D%3D 10.1016/S1053-2498(00)00114-5 Densem CG, Hutchinson IV, Cooper A, et al. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculo-pathy following cardiac transplantation. J Heart Lung Transplant 2000; 19: 551–6
88. 88. IV Hutchinson 1999 The role of transforming growth factor-beta in transplant rejection Transplant Proc 31 9S 13S 10576034 1:CAS:528:DyaK1MXntlektLk%3D 10.1016/S0041-1345(99)00785-X Hutchinson IV. The role of transforming growth factor-beta in transplant rejection. Transplant Proc 1999; 31: 9S–13S
89. 89. A Mallat AM Preaux S Blazejewski 1995 Interferon-alfa and interferon-gamma inhibit proliferation and collagen-synthesis of human Ito cells in culture Hepatology 21 1003 10 7705772 1:CAS:528:DyaK2MXls1KlsLc%3D 10.1002/hep.1840210418 Mallat A, Preaux AM, Blazejewski S, et al. Interferon-alfa and interferon-gamma inhibit proliferation and collagen-synthesis of human Ito cells in culture. Hepatology 1995; 21: 1003–10
90. 90. DC Rockey JJ Maher G Gabbiani 1991 Interferon-gamma (IFN-gamma) inhibits expression of smooth-muscle actin and type-I collagen messenger-RNA in rat hepatic lipocytes Hepatology 14 A189 [abstract] Rockey DC, Maher JJ, Gabbiani G, et al. Interferon-gamma (IFN-gamma) inhibits expression of smooth-muscle actin and type-I collagen messenger-RNA in rat hepatic lipocytes [abstract]. Hepatology 1991; 14: A189
91. 91. V Pravica A Asderakis C Perrey 1999 In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene Eur J Immunogenet 26 1 3 10068907 1:CAS:528:DyaK1MXhvVOkt74%3D 10.1046/j.1365-2370.1999.00122.x Pravica V, Asderakis A, Perrey C,et al. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999; 26: 1–3
92. 92. M Awad V Pravica C Perrey 1999 CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis Hum Immunol 60 343 6 10363726 1:STN:280:DyaK1M3ptVeqtg%3D%3D 10.1016/S0198-8859(98)00133-5 Awad M, Pravica V, Perrey C, et al. CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol 1999; 60: 343–6
93. 93. A Asderakis D Sankaran P Dyer 2001 Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation Transplantation 71 674 8 11292301 1:CAS:528:DC%2BD3MXivVGksLs%3D 10.1097/00007890-200103150-00018 Asderakis A, Sankaran D, Dyer P, et al. Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation. Transplantation 2001; 71: 674–8
94. 94. CA Chambers JP Allison 1999 Costimulatory regulation of T cell function Curr Opin Cell Biol 11 203 10 10209159 1:CAS:528:DyaK1MXisFWlsb4%3D 10.1016/S0955-0674(99)80027-1 Chambers CA, Allison JP. Costimulatory regulation of T cell function. Curr Opin Cell Biol 1999; 11:203–10
95. 95. ZH Dai FG Lakkis 1999 The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection Curr Opin Immunol 11 504 8 10508707 1:CAS:528:DyaK1MXmslahsL4%3D 10.1016/S0952-7915(99)00008-4 Dai ZH, Lakkis FG. The role of cytokines, CTLA-4 and costimulation in transplant tolerance and rejection. Curr Opin Immunol 1999; 11: 504–8
96. 96. OP Kristiansen ZM Larsen F Pociot 2000 CTLA-4 in autoimmune diseases — a general susceptibility gene to autoimmunity? Genes Immun 1 170 84 11196709 1:CAS:528:DC%2BD3cXktlyhtbo%3D 10.1038/sj.gene.6363655 Kristiansen OP, Larsen ZM, Pociot F. CTLA-4 in autoimmune diseases — a general susceptibility gene to autoimmunity? Genes Immun 2000; 1: 170–84
97. 97. T Kouki P Sawai CA Gardine 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease J Immunol 165 6606 11 11086105 1:CAS:528:DC%2BD3cXosFOhtr4%3D Kouki T, Sawai P, Gardine CA, et al. CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J Immunol 2000; 165: 6606–11
98. 98. A Minguela L Marin A Torio 2000 CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant Hum Immunol 61 658 69 10880736 1:CAS:528:DC%2BD3cXksFGjt7s%3D 10.1016/S0198-8859(00)00113-0 Minguela A, Marin L, Torio A, et al. CD28/CTLA-4 and CD80/CD86 costimulatory molecules are mainly involved in acceptance or rejection of human liver transplant. Hum Immunol 2000; 61: 658–69
99. 99. K Agarwal DEJ Jones AK Daly 2000 CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis J Hepatol 32 538 41 10782900 1:CAS:528:DC%2BD3cXisFOjsb0%3D 10.1016/S0168-8278(00)80213-5 Agarwal K, Jones DEJ, Daly AK, et al. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 2000; 32: 538–41
100. 100. K Agarwal AJ Czaja DEJ Jones 2000 Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis Hepatology 31 49 53 10613727 1:CAS:528:DC%2BD3cXks1KqtQ%3D%3D 10.1002/hep.510310110 Agarwal K, Czaja AJ, Jones DEJ, et al. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis. Hepatology 2000; 31: 49–53
101. 101. CJ Raport J Gosling VL Schweickart 1996 Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1 beta, and MIP-1 alpha J Biol Chem 271 17161 6 8663314 1:CAS:528:DyaK28XksFamsbc%3D 10.1074/jbc.271.29.17161 Raport CJ, Gosling J, Schweickart VL, et al. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1 beta, and MIP-1 alpha. J Biol Chem 1996; 271: 17161–6
102. 102. S Segerer Y Cui F Eitner 2001 Expression of chemokines and chemokine receptors during human renal transplant rejection Am J Kidney Dis 37 518 31 11228176 1:CAS:528:DC%2BD3MXit1ektLs%3D 10.1053/ajkd.2001.22076 Segerer S, Cui Y, Eitner F, et al. Expression of chemokines and chemokine receptors during human renal transplant rejection. Am J Kidney Dis 2001; 37: 518–31
103. 103. IP Hall A Wheatley G Christie 1999 Association of CCR5 del 32 with reduced risk of asthma Lancet 354 1264 5 10520641 1:STN:280:DyaK1MvkvV2msw%3D%3D 10.1016/S0140-6736(99)03425-X Hall IP, Wheatley A, Christie G, et al. Association of CCR5 del 32 with reduced risk of asthma. Lancet 1999; 354: 1264–5
104. 104. M Fischereder B Luckow B Hocher 2001 CC chemokine receptor 5 and renal-transplant survival Lancet 357 1758 61 11403814 1:CAS:528:DC%2BD3MXkt1Khsrg%3D 10.1016/S0140-6736(00)04898-4 Fischereder M, Luckow B, Hocher B, et al. CC chemokine receptor 5 and renal-transplant survival. Lancet 2001; 357: 1758–61
105. 105. DH Adams LF Wang D Burnett 1990 Neutrophil activation — an important cause of tissue-damage during liver allograft-rejection Transplantation 50 86 91 2164266 1:STN:280:DyaK3czht1Kntg%3D%3D 10.1097/00007890-199007000-00016 Adams DH, Wang LF, Burnett D, et al. Neutrophil activation — an important cause of tissue-damage during liver allograft-rejection. Transplantation 1990; 50:86–91
106. 106. TE Starzl AJ Demetris M Trucco 1993 Cell-migration and chimerism after whole-organ transplantation: the basis of graft acceptance Hepatology 17 1127 52 8514264 1:STN:280:DyaK3s3ptlWmsQ%3D%3D 10.1002/hep.1840170629 Starzl TE, Demetris AJ, Trucco M, et al. Cell-migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17:1127–52
107. 107. G Gambaro F Anglani A D’Angelo 2000 Association studies of genetic polymorphisms and complex disease Lancet 355 308 11 10675088 1:CAS:528:DC%2BD3cXhtlCgtr8%3D 10.1016/S0140-6736(99)07202-5 Gambaro G, Anglani F, D’Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet 2000; 355: 308–11
108. 108. JA Todd 1999 Interpretation of results from genetic studies of multifactorial diseases Lancet 354 SI15 6 10437850 10.1016/S0140-6736(99)90243-X Todd JA. Interpretation of results from genetic studies of multifactorial diseases. Lancet 1999; 354: SI15–6
109. 109. Freely associating. Nat Genet 1999; 22: 1–2
110. 110. N Risch 2000 Searching for genetic determinants in the new millenium Nature 405 847 56 10866211 1:CAS:528:DC%2BD3cXksV2gtLs%3D 10.1038/35015718 Risch N. Searching for genetic determinants in the new millenium. Nature 2000; 405: 847–56
111. 111. K Weiss J Terwilliger 2000 How many diseases does it take to map a gene with SNPs? Nat Genet 26 151 7 11017069 1:CAS:528:DC%2BD3cXntlGmsrc%3D 10.1038/79866 Weiss K, Terwilliger J. How many diseases does it take to map a gene with SNPs? Nat Genet 2000; 26: 151–7
112. 112. AVS Hill 2001 Immunogenetics and genomics Lancet 357 2037 41 11438157 1:CAS:528:DC%2BD3MXks1Oisbg%3D 10.1016/S0140-6736(00)05117-5 Hill AVS. Immunogenetics and genomics. Lancet 2001; 357: 2037–41